Schering Plough and Sepracor have settled a patent dispute with Indian generics maker Dr. Reddy's over Clarinex. The settlement brings forward the end of patent exclusivity on Clarinex to 2012. Previously, the assumption had been that Schering's exclusivity with Clarinex would last until 2020.
SCHERING-Plough Corp. is said to be negotiating final terms of a consent decree with the Food & Drug Administration over manufacturing woes, which prevent a Clarinex launch. ... SCHERING-Plough Corp. is said to be negotiating final terms of a consent decree with the Food...
The syrup formula can also reduce the appearance of hives in children. Because many people are unable to easily take pills or tablets, Clarinex has provided a solution. For those who need another method, Clarinex Redi-tabs melt easily in the mouth. These also provide 24-hour relief and come in a fruit flavor.
|
